Adverse Drug Events Reporting Features

• Sodium Bicarbonate Use in the Emergency Department Two recent reviews may change how you use bicarb in the ED.
  Medscape Emergency Medicine, December 20, 2023
• Spending the Holidays With GLP-1 RAs: 5 Things to Know Should patients on new antiobesity medications change their eating over the holidays? Beverly Tchang, MD, offers five tips that she shares with her patients.
  Medscape Diabetes & Endocrinology, December 19, 2023
• The Top Cardiology Trials of 2023   For this year's review, Bob Harrington and Mike Gibson revisit the major cardiology conferences -- from ACC in New Orleans to AHA in Philly.
  theheart.org on Medscape, December 15, 2023
• Life After Cancer: A New Outlook on Survivorship: Health and Mental Health   Experts discuss tools and techniques used by patients and practitioners to better identify and address the psychosocial issues that cancer survivors often face.
  Medscape TV, December 15, 2023
• Cysteamine and Melasma Cysteamine is a natural agent that has recently garnered attention primarily for one indication: melasma.
  MDedge, December 15, 2023
• SABCS 2023: Highlights in HR+/HER2- Breast Cancer   Tarah J. Ballinger, MD, provides her biggest takeaways from SABCS 2023 in HR+/HER2- breast cancer.
  Medscape, December 13, 2023
• How to Prescribe Zepbound Recently approved tirzepatide joins semaglutide as an option for patients with obesity. Beverly Tchang, MD, offers her recommendations based on her experience for prescribing.
  Medscape Diabetes & Endocrinology, December 12, 2023
• Why I Don't Worry About Nephrotoxicity With Zosyn   Dr Paul Auwaerter explains why a warning about nephrotoxicity doesn't influence his decision to use Zosyn when it's indicated.
  Medscape Infectious Diseases, December 11, 2023
• The Truth About Vaping   The idea that vaping is harmless is going up in smoke. What would you tell your own kids or grandkids about e-cigarette use?
  Medscape Family Medicine, December 11, 2023
• Dec 08 2023 This Week in Cardiology   Three aspects of the recent AF guideline documents and a possible new treatment of POTS are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, December 08, 2023
• Dr Christmas on Managing Menopausal Symptoms   Dr Monica Christmas's gift to The Curbsiders is expert advice on using hormonal and nonhormonal therapies in perimenopause.
  The Curbsiders, December 05, 2023
• Episode 6: Thinking Beyond TROP2 at ESMO 2023   What were the biggest takeaways from ESMO 2023 related to TNBC and IBC? Tune in to hear experts Drs Kevin Kalinsky and Filipa Lynce discuss.
  Medscape, December 05, 2023
• ASH President Reflects Before Annual Meeting on Hematology   Robert Brodsky, MD, thinks back on his year as president of the American Society of Hematology and the latest advances in treating blood disorders.
  WebMD, December 04, 2023
• Dec 01 2023 This Week in Cardiology   More from AHA including SGLT2 inhibitors, blood transfusion after MI; cracks in the armor of Factor XI inhibitors; and renal denervation are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, December 01, 2023
• How Low Should You Go? Is Very Low LDL-C Safe? Drs Connie Newman and Seth Martin highlight the evidence supporting the safety of very low LDL-C levels, and how maintaining low levels protects against CV events such as MI and stroke.
  American College of Cardiology & Medscape , December 01, 2023
• Medscape Physicians and EHRs Report 2023 Physicians reveal how long and how their medical practices have used electronic health records (EHRs), where they have ongoing concerns, and where they hope for improvements in EHR systems.
  Medscape News Slideshows, November 29, 2023
• A Pill for Psoriasis: The Latest Oral Medications Kylee Wang and Dr Jennifer Soung give an overview of the current oral therapies for psoriasis, plus a look at potential new agents.
  Medscape Dermatology, November 28, 2023
• Key Data on Macular Degeneration From AAO 2023   Key data on treatment of macular degeneration, from AAO 2023, include extended study results on pegcetacoplan and avacincaptad pegol, as well as findings in gene therapy, as reported by Dr Sunir Garg.
  Medscape, November 28, 2023
• Myasthenia Gravis Highlights From AANEM 2023   Key data on myasthenia gravis from AANEM 2023 include results on the ADAPT+ study of efgartigimod, inequities in diagnosis, and eculizumab use in pregnancy, as reviewed by Dr Nicholas Silvestri.
  Medscape, November 22, 2023
• An Update on Lipoprotein(a): The Latest on Testing, Treatment, and Guideline Recommendations This review highlights the current state of Lipoprotein(a), including updates from clinical trial outcomes and guideline recommendations supporting once-in-a-lifetime measurement in most individuals with increased risk of atherosclerotic CVD.
  ACC.org, November 22, 2023